Our and other studies support that the inhibition of CD38 by 78c could serve as an adjunctive therapy for aging associated diseases, such as aging-associated periodontitis, to inhibit periodontal inflammation, attenuate osteoclastogenesis and alveolar bone resorption, alleviate oxidative stress, and prolong the health span of human beings. This evidence concerns the gene CD38 and glycogen storage disease VI.